Who is sponsoring NCT04895267?

NCT04895267 is sponsored by Elias Manjarrez.

What drugs are being tested in NCT04895267?

Interventions in NCT04895267: Low-field thoracic magnetic stimulation (LF-ThMS).

What condition does NCT04895267 study?

NCT04895267 studies COVID-19, Acute Respiratory Failure, Oxygen Deficiency.

Is NCT04895267 still recruiting?

NCT04895267 is currently status unknown. Last updated 16 March 2022.

Last reviewed 2022-03-16 · How we verify

NCT04895267

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients

Status unknown NA Last updated 16 March 2022

What this trial tests

NA trial testing Low-field thoracic magnetic stimulation (LF-ThMS) in COVID-19 in 17 participants. Status unknown.

Timeline

3 July 2020

Primary endpoint
3 August 2022

17 September 2022

Quick facts

Lead sponsor	Elias Manjarrez
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	17
Start date	3 July 2020
Primary completion	3 August 2022
Estimated completion	17 September 2022
Sites	1 location across Mexico

Drugs / interventions tested

Low-field thoracic magnetic stimulation (LF-ThMS)

Conditions studied

COVID-19 — all drugs for COVID-19 →
Acute Respiratory Failure — all drugs for Acute Respiratory Failure →
Oxygen Deficiency — all drugs for Oxygen Deficiency →

Sponsor

Elias Manjarrez

Who can join

Adults 20 to 85, any sex, with COVID-19 or Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to present a proof-of-concept that a 30 minutes single-session of low-field thoracic magnetic stimulation (LF-ThMS) on the dorsal thorax can be employed to increase oxygen saturation (SpO2) levels in coronavirus disease (COVID-19) participants significantly. The investigators (Saul M. Dominguez-Nicolas and Elias Manjarrez) hypothesized that the variables associated with LF-ThMS, as hyperthermia, frequency, and magnetic flux density in the dorsal thorax, might be correlated to SpO2 levels in these participants. The investigators designed a single-blind, sham-controlled, crossover study on COVID-19 participants who underwent two sessions of the study (real and sham LF-ThMS), and other COVID-19 participants who underwent only the real LF-ThMS.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Low-field thoracic magnetic stimulation increases peripheral oxygen saturation levels in coronavirus disease (COVID-19) patients: A single-blind, sham-controlled, crossover study.
Dominguez-Nicolas SM, Manjarrez E. · · 2021 · cited 4× · PMID 34622862 · DOI 10.1097/md.0000000000027444
Low-field thoracic magnetic stimulation increases peripheral oxygen saturation levels in coronavirus disease (COVID-19) patients: a single-blind, sham-controlled, crossover study
Dominguez-Nicolas SM, Manjarrez E. · · 2021 · DOI 10.1101/2021.05.21.21256456

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04895267 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elias Manjarrez
Last refreshed: 16 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04895267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing